Announcements - Translational Cancer Research

Posted: 2022-09-30

Testimonials from prestigious Editorial Board Members

Prestigious editorial board members of Translational Cancer Research (TCR) recommend the journal according to their knowledge to TCR and their personal interaction with it. The editorial team appreciate supports from the Editorial Board Members.

Posted: 2022-06-30

New Impact Factor for Translational Cancer Research: 0.496

We are pleased to announce that the Translational Cancer Research (TCR) has attained its latest impact factor update for the 2021 citation year: 0.496.

Posted: 2021-12-18

Translational Cancer Research is indexed in PubMed/PMC: A tremendous step forward

We are delighted to announce that Translational Cancer Research (TCR) has passed the Scientific Quality Review by NLM for PMC. TCR is now indexed in PubMed/PMC, two important and extensive biomedical digital databases, which means publications in TCR will enjoy maximum exposure. All articles published in TCR from 2019 onwards will be available in PubMed/PMC within 1-2 months.

Posted: 2021-11-05

Translational Cancer Research (TCR) is now a member of Committee on Publication Ethics (COPE)

Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Translational Cancer Research (TCR) is among the list of COPE membership.

Posted: 2021-07-01

New Impact Factor for Translational Cancer Research: 1.241

We are pleased to announce that the Translational Cancer Research (TCR) has attained its latest impact factor update for the 2020 citation year: 1.241.

Posted: 2021-01-18

TCR 2020 Annual Report

Greetings from Editor-in-Chief and Editorial Office of Translational Cancer Research!

Posted: 2020-06-30

New Impact Factor for Translational Cancer Research: 0.986

We are pleased to announce that the Translational Cancer Research (TCR) has attained its latest impact factor update for the 2019 citation year: 0.986.

Posted: 2020-04-29

AME entered an official partnership with Publons to enhance wide-ranging recognition for reviewers

AME Publishing Company entered an official partnership with Publons, a product of Clarivate Analytic Company (which owns Web of Science, EndNote, ScholarOne, among many others), as of April 2020.

Posted: 2020-03-18

Implementation of transparent peer review at Translational Cancer Research

With a commitment to openness and accountability, and to increase the level of transparency throughout our peer review process, our editorial office has decided to implement a transparent peer review process as an option for all manuscripts submitted to TCR from March 19, 2020.

Posted: 2020-01-17

TCR Annual Report (2019)

Greetings from Editor-in-Chief and Editorial Office of Translational Cancer Research!

Posted: 2019-10-11

Application of the CARE Guideline as reporting standard in Translational Cancer Research

Translational Cancer Research welcomes case reports which are supposed to report new observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in the fields of medicine.

Posted: 2019-09-12

Translational Cancer Research (TCR) is going to publish monthly starting in September 2019!

Posted: 2019-06-21

New Impact Factor for Translational Cancer Research: 1.07

Posted: 2019-01-22

TCR Annual Report (2018)

Posted: 2018-01-30

TCR Annual Report (2017)

Posted: 2017-12-06

Welcome to the 2017 Taiwan Society for Therapeutic Radiology and Oncology Conference: “Bring Insight into Impacts” and Both Sides across the Strait Forum

Posted: 2017-11-30

Welcome to Pancreas 2018 Innovations in the Care of Pancreatic Cancer and Call for Papers

Posted: 2017-11-01

Welcome to the 4th Hong Kong International Oncology Symposium 2017

Posted: 2017-10-01

Join us at the 16th Annual Meeting of Taiwan Association of Thoracic & Cardiovascular Surgery

The 16th Annual Meeting of Taiwan Association of Thoracic & Cardiovascular Surgery will be held in Taipei on October 28 and 29, 2017.

Posted: 2017-07-18

Welcome to join us on IASLC 18th World Conference on Lung Cancer

Posted: 2017-01-19

TCR Annual Report (2016)

Posted: 2016-09-19

Withdrawal Policy

Posted: 2016-09-06

AME Publishing Company successfully closed Series A funding of 4 million USD

Posted: 2016-06-14

2015 Impact Factor of Translational Cancer Research: 1.757

It is great to announce that Translational Cancer Research (TCR) gains its 2015 impact factor: 1.757

Posted: 2016-03-14

TCR Annual Report of 2015

Posted: 2015-10-14

Welcome to Join Us at the 2015 ASTRO

We sincerely welcome you to visit our booth “AME Publishing Company” at No. 300 in Hall A. Look forward to meeting you in San Antonio!

Posted: 2015-10-03

Translational Cancer Research is indexed in SCIE

Posted: 2015-08-24

Translational Cancer Research is indexed in Scopus

With pleasure, we are here to announce that Translational Cancer Research (TCR) has been accepted for inclusion in Scopus.

Posted: 2014-03-20

Conferences to attend in 2014 of TCR

The editorial team of Translational Cancer Research is attending the following conferences in 2014. Your joining us will be warmly welcomed.

Posted: 2013-11-25

Special issue: Intraoperative Radiotherapy (IORT)

Guest Editors: Frederik Wenz and Elena Sperk, University Medical Center Mannheim, Department of Radiation Oncology, University of Heidelberg, Germany